Ann D. Kwong
Chief Tech/Sci/R&D Officer bij PARDES BIOSCIENCES, INC.
Profiel
Ann D.
Kwong is the founder of Trek Therapeutics PBC.
She is currently the Executive Vice President-Research at Pardes Biosciences, Inc. Her former position was as the Executive Vice President-Research & Development at Dewpoint Therapeutics, Inc. Dr. Kwong received her undergraduate and graduate degrees from The University of Chicago.
Actieve functies van Ann D. Kwong
| Bedrijven | Functie | Begin |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Trek Therapeutics PBC
 Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Trek Therapeutics PBC is a for-profit company based in Cambridge, MA. The private company's mission is to develop medicines to treat infectious diseases and make them available to populations in need. The founders of the company, Jerome B. Zeldis and Ann D. Kwong, have collectively participated in developing seven approved antiviral drugs. The company aims to profitably develop safe, novel medicines for infectious diseases at affordable prices. Ann D. Kwong has been the CEO since incorporation. | Founder | - |
Eerdere bekende functies van Ann D. Kwong
| Bedrijven | Functie | Einde |
|---|---|---|
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Opleiding van Ann D. Kwong
| The University of Chicago | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Trek Therapeutics PBC
Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Trek Therapeutics PBC is a for-profit company based in Cambridge, MA. The private company's mission is to develop medicines to treat infectious diseases and make them available to populations in need. The founders of the company, Jerome B. Zeldis and Ann D. Kwong, have collectively participated in developing seven approved antiviral drugs. The company aims to profitably develop safe, novel medicines for infectious diseases at affordable prices. Ann D. Kwong has been the CEO since incorporation. | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
